The R251Q mutation of LSD1 promotes invasion and migration of luminal breast cancer cells

Citation:

Yu Zhang, Tong Wu, Yajing Wang, Xinyue Zhao, Bo Zhao, Xue Zhao, Qinglin Zhang, Yue Jin, Zhe Li, and Xin Hu. 2020. “The R251Q mutation of LSD1 promotes invasion and migration of luminal breast cancer cells.” Int J Biol Macromol, 164, Pp. 4000-4009.

Abstract:

LSD1 (KDM1A), a histone demethylase, plays important roles in breast cancer. The breast cancer patients with LSD1 mutation show significantly worse outcomes compared to those without LSD1 mutation. The R251Q mutation of LSD1 increases the invasion and migration of luminal breast cancer cells. Furthermore, the R251Q mutation of LSD1 alters the expression of genes that modulates the epithelial to mesenchymal transition. Additionally, the R251Q mutation impairs the H3K4me2 demethylation activity of LSD1 by abolishing the interaction between LSD1 and CoREST, which leads to the increased expression of TRIM37, a histone H2A ubiquitin ligase that regulates the expression of E-cadherin. Collectively, our results suggest that the R251Q mutation abolishes the tumor suppressive effects of LSD1 on luminal breast cancer cells by disrupting the formation of functional LSD1/CoREST/HDAC complexes.